Mycophenolate Mofetil for Injection USP, 500 mg/Vial, Single Dose Vial, 4 vials per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV, 26505 USA, Made in India, NDC 67457-386-00 (vial label) & NDC 67457-386-81 (carton label).
Published August 5, 2026 · Recall initiated: July 2, 2026
Summary
FDA records drug Class II recall D-0734-2026, published August 5, 2026 and initiated July 2, 2026. Recalling firm: MYLAN PHARMACEUTICALS INC; Status: Ongoing; Reported quantity: 5688 vials; Lot: Lot #: 3241653, Exp 4/30/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of precipitate
What to do
Voluntary: Firm initiated · Letter
Get an email if MYCOPHENOLATE MOFETIL has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- MYCOPHENOLATE MOFETIL
- Manufacturer
- MYLAN PHARMACEUTICALS INC
- Distributor
- USA Nationwide
- Lot
- Lot #: 3241653, Exp 4/30/2027
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACarton label: Mycophenolate Mofetil for injection, USP, 500 mg/vial, Sterile, 4 Single Dose Vials, Rx only,September 9, 2026
- FDAAzelaic Acid Gel, 15%, 50 gram tubes, For Topical Use only, Rx only, Distributed by: Glenmark PharmaceuticalsAugust 5, 2026
- FDADabigatran Etexilate Capsules, 150 mg, 60-count (6x10) blister pack further packaged in a carton, Rx only,August 5, 2026
- FDADorzolamide HCl and Timolol Maleate Ophthalmic Solution, USP, 2%/0.5%, 10mL - bottle, Rx only, ManufacturedAugust 5, 2026
- FDAMycophenolate Mofetil for Oral Suspension, USP, 200 mg/mL, Rx Only, bottle, Manufactured for: VistaPharm,November 15, 2023
- FDAMycophenolate Mofetil for Injection, USP 500 mg, 4 Single Dose Vials, Rx Only, Distributed by: ParMay 15, 2019
Questions about this recall
Was Mycophenolate Mofetil for Injection USP, 500 mg/Vial, Single Dose Vial, 4 vials per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV, 26505 USA, Made in India, NDC 67457-386-00 (vial label) & NDC 67457-386-81 (carton label). recalled?
Yes. FDA published recall D-0734-2026 on August 5, 2026. Reported hazard: Presence of precipitate
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: MYCOPHENOLATE MOFETIL.